Although insulin therapy is the best treatment option for T1DM patients, chronic insulinization may cause hypoglycemia episodes [3], increased body weight gain [4] and increased oxidative stress that results in endothelial dysfunction and inflammation [5]. The gene discussed is INS; the disease is endothelial dysfunction.